Weekly CEO News from Richard Ingram
July 10, 2017

Shares of biotech giant Celgene (CELG) may be worth $200 per share if peak sales of late-stage assets, including luspatercept, ozanimod, and GED301 are met, said analyst Ying Huang. LUSPATERCEPT: Luspatercept is an experimental drug in clinical trials for the

Read more

What’s the safest investment as the global economy enters increasingly risky, troubled times? I’ve reviewed hundreds of academic papers, investment reports and newsletters and researched long-term strategies and backtests and reached one conclusion. I won’t keep you in suspense: it’s bat

Read more

Former IMF chief economist Ken Rogoff warned today on CNBC that he was concerned about China. Specifically, he worried that country might “export a recession” to the rest of Asia if not the rest of the world. I’m not sure if he has been

Read more

Video Length – 00:14:12

Today’s stock picks Long Jacobs Engineering Group (JEC) Long Comerica (CMA) Short Wix.com (WIX)

No doubt, elements of the current market condition can make one uneasy. Like driving a hotrod going 100 mph without a seatbelt on, getting long up at these levels can feel death defying. Just look at the brick and mortar

Read more

Tom Denham, the editor of Elliott Wave International’s Metals Pro Service, tells you about the importance of the market’s price momentum and explains what momentum is saying about the trend in gold. Watch this new interview to get Tom’s latest outlook

Read more

The Chart of the Day belongs to Pieris Pharmaceuticals (PIRS). I found the biopharmaceutical stock by using Barchart to sort today’s All Time High list first for the highest Weighted Alpha, then again for technical buy signals of 80% or more. Since the Trend Spotter signaled

Read more

Brandon Macdonald, the CEO of Fireweed Zinc joined me to discuss the company’s large Zinc-Lead-Silver deposits known as Tom and Jason. Fireweed has an extremely tight share structure, experienced management team, huge exploration potential and is well poised to capitalize on

Read more

There’s been a lot of talk about the so-called FAANG stocks and parallels being drawn against the 2000’s dot com bubble. With S&P500 valuations steadily pushing higher vs history and relative to global equities, it’s somewhat understandable.  But this ain’t

Read more